Cellular immune response induced by surface immunogenic protein with AbISCO-100 adjuvant vaccination decreases group B Streptococcus vaginal colonization

Baker, 2017, Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization, Vaccine, 35, 1273, 10.1016/j.vaccine.2017.01.029 Bengtsson, 2011, ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation, Expert Rev. Vaccines, 10, 401, 10.1586/erv.11.25 Brodeur, 2000, Identification of group B streptococcal Sip protein, which elicits cross-protective immunity, Infect. Immun., 68, 5610, 10.1128/IAI.68.10.5610-5618.2000 Diaz-Dinamarca, 2018, Immunization with a mixture of nucleoprotein from human metapneumovirus and AbISCO-100 adjuvant reduces viral infection in mice model, Viral Immunol., 31, 306, 10.1089/vim.2017.0159 Diaz-Dinamarca, 2018, Immunization with a mixture of nucleoprotein from human metapneumovirus and AbISCO-100 adjuvant reduces viral infection in mice model, Viral Immunol., 31, 306, 10.1089/vim.2017.0159 Diaz-Dinamarca, 2018, The optimisation of the expression of recombinant surface immunogenic protein of group B Streptococcus in Escherichia coli by response surface methodology improves humoral immunity, Mol. Biotechnol., 60, 215, 10.1007/s12033-018-0065-8 Diaz-Dinamarca, 2018, Oral vaccine based on a surface immunogenic protein mixed with alum promotes a decrease in Streptococcus agalactiae vaginal colonization in a mouse model, Mol. Immunol., 103, 63, 10.1016/j.molimm.2018.08.028 Dilai, 2018, Impact of mixed equine influenza vaccination on correlate of protection in horses, Vaccines (Basel), 6 Duewell, 2011, ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells, J. Immunol., 10.4049/jimmunol.1004114 Gendrin, 2017, A nonhemolytic group B Streptococcus strain exhibits hypervirulence, J. Infect. Dis., 217, 983, 10.1093/infdis/jix646 Guttormsen, 2008, Functional activity of antisera to group B streptococcal conjugate vaccines measured with an opsonophagocytosis assay and HL-60 effector cells, Hum. Vaccin., 4, 370, 10.4161/hv.4.5.5988 Ippolito, 2010, Group B Streptococcus serotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distribution, BMC Infect. Dis., 10, 336, 10.1186/1471-2334-10-336 Lefeber, 2003, Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3, Infect. Immun., 71, 6915, 10.1128/IAI.71.12.6915-6920.2003 Lin, 2018, Status of group B streptococcal vaccine development, Clin. Exp. Vaccine Res., 7, 76, 10.7774/cevr.2018.7.1.76 Martin, 2002, Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein, Infect. Immun., 70, 4897, 10.1128/IAI.70.9.4897-4901.2002 Martinez, 2015, Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation, Sci. Rep., 5, 8925, 10.1038/srep08925 Morein, 2004, Current status and potential application of ISCOMs inveterinary medicine, Adv. Drug Deliv. Rev., 56, 1367, 10.1016/j.addr.2004.02.004 Muruganandah, 2018, A Systematic Review: the Role of Resident memory t cells in infectious Diseases and their Relevance for vaccine Development, Front. Immunol., 9, 1574, 10.3389/fimmu.2018.01574 Pearse, 2005, ISCOMATRIX® adjuvant for antigen delivery, Drug Deliv Rev., 465, 10.1016/j.addr.2004.09.006 Romero-Saavedra, 2015, Characterization of two metal binding lipoproteins as vaccine candidates for Enterococcal infections, PLoS One, 10, 10.1371/journal.pone.0136625 Russell, 2017, Maternal colonization with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses, Clin. Infect. Dis., 65, S100, 10.1093/cid/cix658 Sadarangani, 2018, Protection against invasive infections in children caused by encapsulated bacteria, Front. Immunol., 9 Sallusto, 2010, From vaccines to memory and back, Immunity, 33, 451, 10.1016/j.immuni.2010.10.008 Soerens, 2016, Regulatory T cells are essential to promote proper CD4 T-cell priming upon mucosal infection, Mucosal Immunol., 9, 1395, 10.1038/mi.2016.19 Soto, 2018, 2, 1 Teatero, 2017, Serotype distribution, population structure, and antimicrobial resistance of group B Streptococcus strains recovered from colonized pregnant women, J. Clin. Microbiol., 55, 412, 10.1128/JCM.01615-16 Vasquez, 2015, Oral administration of recombinant Neisseria meningitidisPorA genetically fused to H. Pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant, Hum. Vaccin. Immunother., 11, 776, 10.1080/21645515.2015.1011011 Vekemans, 2018, Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics, Vaccine Vornhagen, 2017, Perinatal group B streptococcal infections: virulence factors, immunity, and prevention strategies, Trends Microbiol., 25, 919, 10.1016/j.tim.2017.05.013 Wilson, 2012, ISCOMATRIX vaccines mediate C D8 + T- cell cross-priming by a MyD88-dependent signaling pathway, Immunol. Cell Biol., 90, 540, 10.1038/icb.2011.71 Xue, 2010, Intranasal immunization with GBS surface protein Sip and ScpB induces specific mucosal and systemic immune responses in mice, FEMS Immunol. Med. Microbiol., 58, 202, 10.1111/j.1574-695X.2009.00623.x